Stock NNVC NANOVIRICIDES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart NanoViricides, Inc.

Equities

NNVC

US6300873022

Market Closed - Nyse
Other stock markets
 01:30:00 06/06/2024 am IST 		5-day change 1st Jan Change
2.43 USD +0.41% Intraday chart for NanoViricides, Inc. 0.00% +138.24%
04/06 NanoViricides, Inc. Reports on the Highly Desirable Blood Concentration Profile of its Lead Clinical Stage Broad-Spectrum Antiviral Agent NV-387 Upon Intravenous CI
29/05 NanoViricides, Inc. Intends to Revolutionize Treatment of Viral Infections Including RSV, COVID, Influenzas and More CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
NANOVIRICIDES, INC. Stock NanoViricides, Inc.
 28.62M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 125B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 109B
BIONTECH SE Stock BioNTech SE
 24.74B -
ARGENX SE Stock argenx SE
 22.67B -
GENMAB A/S Stock Genmab A/S
 18.14B
  1. Stock Market
  2. Equities
  3. NNVC Stock
  4. Charts NanoViricides, Inc.
  5. Sector Chart